Serge Pharma Private Limited, a active private limited company, was established on 01 June 2017 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U51909MP2017PTC043450. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.61 Cr.
It upholds a compliant status. Its leadership includes Anju Soni (Director), Vijay Laxmi Soni (Director). Past directors included Ram Nivas, Anju Soni, Vijay Laxmi Soni. It holds no open charges and ₹10.54 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 201, J.V. Complex, Part -A,, Munshipal No. 2/13 Dr. Roshansingh Bhandari Marg, Indore, Madhya Pradesh, 452001.
U51909MP2017PTC043450
043450
01 June 2017
₹2.00 Cr
₹1.61 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Serge Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anju Soni | Director | 10 Feb 2022 | Current |
| Vijay Laxmi Soni | Director | 10 Feb 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
| Pramod Abcsdd | Director | 29 Mar 2021 | Past |
| Pramod Abcsdd | Director | 30 Mar 2024 | Past |
| Pramod Abcsdd | Director | 30 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Serge Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.33% increase. The company also saw a substantial improvement in profitability, with a 25.78% increase in profit. The company's net worth Soared by an impressive increase of 121.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Serge Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹105,400,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jul 2024 | Others | ₹10.54 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Serge Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Serge Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serge Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 10 Jul 2024 via Charge ID 100968598 with Others was fully satisfied on 12 Nov 2024. was recorded as a recent event.
The activity Serge Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity A charge with Others amounted to Rs. 10.54 Cr with Charge ID 100968598 was registered on 10 Jul 2024. was completed.
Serge Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
The activity Anju Soni was appointed as a Director was appointed as a Director on 10 Feb 2022 & has been associated with this company since 3 years 9 months . was completed.
The activity Vijay Laxmi Soni was appointed as a Director was appointed as a Director on 10 Feb 2022 & has been associated with this company since 3 years 9 months . was completed.
The CIN of Serge Pharma Private Limited is U51909MP2017PTC043450.
Serge Pharma Private Limited is headquartered at Office No. 201, J.V. Complex, Part -A,, Munshipal No. 2/13 Dr. Roshansingh Bhandari Marg, Indore, Madhya Pradesh, 452001.
Serge Pharma Private Limited was incorporated on 01 June 2017.
The current directors of Serge Pharma Private Limited are
The primary industry of Serge Pharma Private Limited is Trade.
Serge Pharma Private Limited is unlisted.
The authorized capital of Serge Pharma Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.61 Cr.
The compliance status of Serge Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX